Acura Pharmaceuticals, Inc. (ACUR.W)
ACUR.W on CBOE When Trading NASDAQ Global Select Market
4.65USD
8 Feb 2010
4.65USD
8 Feb 2010
Price Change (% chg)
$-0.36 (-7.41%)
$-0.36 (-7.41%)
Prev Close
$4.65
$4.65
Open
--
--
Day's High
$4.87
$4.87
Day's Low
$4.50
$4.50
Volume
11,156
11,156
Avg. Vol
17,501
17,501
52-wk High
$9.00
$9.00
52-wk Low
$4.00
$4.00
About
Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of product candidates providing abuse deterrent features and benefits utilizing its Aversion Technology. The Company’s Aversion Technology platform has been successfully utilized in developing multiple opioid... (more)
No analyst recommendations are available for ACUR.W.
Overall
| Beta: | 0.34 |
| Market Cap (Mil.): | $195.94 |
| Shares Outstanding (Mil.): | 42.97 |
| Annual Dividend: | 0.00 |
| Yield (%): | NA |
Financials
| ACUR.W | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 1.96 | 3.76 |
| EPS (TTM): | -157.70 | -- | -- |
| ROI: | -41.48 | 0.92 | 2.30 |
| ROE: | -41.97 | 1.27 | 2.82 |
King Pharma in pact with Acura to develop painkillers
Oct 31 (Reuters) - King Pharmaceuticals Inc said it has entered into an agreement with Acura Pharmaceuticals Inc to develop painkillers using Acura's Aversion technology.
Competitors
| Price | Change | |
|---|---|---|
| Pain Therapeutics, Inc. (PTIE.OQ) | $5.56 | +0.11 |
| King Pharmaceuticals, Inc. (KG.N) | $11.44 | +0.14 |
| Endo Pharmaceuticals (ENDP.OQ) | $19.63 | +0.10 |
| Elite Pharmaceuticals, Inc. (ELTP.OB) | $0.10 | -0.00 |





Earnings vs
Estimates